Transplantation of bovine adrenocortical cells encapsulated in alginate

Mariya Balyura, Evgeny Gelfgat, Monika Ehrhart-Bornstein, Barbara Ludwig, Zohar Gendlerc, Uriel Barkai, Baruch Zimerman, Avi Rotem, Norman L Block, Andrew V Schally, Stefan R. Bornstein

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Current treatment options for adrenal insufficiency are limited to corticosteroid replacement therapies. However, hormone therapy does not replicate circadian rhythms and has unpleasant side effects especially due to the failure to restore normal function of the hypothalamic-pituitary-adrenal (HPA) axis. Adrenal cell transplantation and the restoration of HPA axis function would be a feasible and useful therapeutic strategy for patients with adrenal insufficiency. We created a bioartificial adrenal with 3D cell culture conditions by encapsulation of bovine adrenocortical cells (BACs) in alginate (enBACs). We found that, compared with BACs in monolayer culture, encapsulation in alginate significantly increased the life span of BACs. Encapsulation also improved significantly both the capacity of adrenal cells for stable, long-term basal hormone release as well as the response to pituitary adrenocorticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6]LHRH. The enBACs were transplanted into adrenalectomized, immunodeficient, and immunocompetent rats. Animals received enBACs intraperitoneally, under the kidney capsule (free cells or cells encapsulated in alginate slabs) or s.c. enclosed in oxygenating and immunoisolating βAir devices. Graft function was confirmed by the presence of cortisol in the plasma of rats. Both types of grafted encapsulated cells, explanted after 21-25 d, preserved their morphology and functional response to ACTH stimulation. In conclusion, transplantation of a bioartificial adrenal with xenogeneic cells may be a treatment option for patients with adrenocortical insufficiency and other stress-related disorders. Furthermore, this model provides a microenvironment that ensures 3D cell-cell interactions as a unique tool to investigate new insights into cell biology, differentiation, tissue organization, and homeostasis.

Original languageEnglish
Pages (from-to)2527-2532
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume112
Issue number8
DOIs
StatePublished - Feb 24 2015

Fingerprint

Transplantation
Adrenal Insufficiency
Gonadotropin-Releasing Hormone
Adrenocorticotropic Hormone
Hormones
Hypothalamic Hormones
Therapeutics
alginic acid
Pituitary Hormones
Cell Transplantation
Circadian Rhythm
Cell Communication
Capsules
Cell Biology
Hydrocortisone
Cell Differentiation
Adrenal Cortex Hormones
Homeostasis
Cell Culture Techniques
Air

Keywords

  • Adrenal
  • Alginate encapsulation
  • Cell transplantation
  • LHRH

ASJC Scopus subject areas

  • General

Cite this

Balyura, M., Gelfgat, E., Ehrhart-Bornstein, M., Ludwig, B., Gendlerc, Z., Barkai, U., ... Bornstein, S. R. (2015). Transplantation of bovine adrenocortical cells encapsulated in alginate. Proceedings of the National Academy of Sciences of the United States of America, 112(8), 2527-2532. https://doi.org/10.1073/pnas.1500242112

Transplantation of bovine adrenocortical cells encapsulated in alginate. / Balyura, Mariya; Gelfgat, Evgeny; Ehrhart-Bornstein, Monika; Ludwig, Barbara; Gendlerc, Zohar; Barkai, Uriel; Zimerman, Baruch; Rotem, Avi; Block, Norman L; Schally, Andrew V; Bornstein, Stefan R.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 112, No. 8, 24.02.2015, p. 2527-2532.

Research output: Contribution to journalArticle

Balyura, M, Gelfgat, E, Ehrhart-Bornstein, M, Ludwig, B, Gendlerc, Z, Barkai, U, Zimerman, B, Rotem, A, Block, NL, Schally, AV & Bornstein, SR 2015, 'Transplantation of bovine adrenocortical cells encapsulated in alginate', Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 8, pp. 2527-2532. https://doi.org/10.1073/pnas.1500242112
Balyura, Mariya ; Gelfgat, Evgeny ; Ehrhart-Bornstein, Monika ; Ludwig, Barbara ; Gendlerc, Zohar ; Barkai, Uriel ; Zimerman, Baruch ; Rotem, Avi ; Block, Norman L ; Schally, Andrew V ; Bornstein, Stefan R. / Transplantation of bovine adrenocortical cells encapsulated in alginate. In: Proceedings of the National Academy of Sciences of the United States of America. 2015 ; Vol. 112, No. 8. pp. 2527-2532.
@article{e4a5867f64734b1a83ea67972bbf3fca,
title = "Transplantation of bovine adrenocortical cells encapsulated in alginate",
abstract = "Current treatment options for adrenal insufficiency are limited to corticosteroid replacement therapies. However, hormone therapy does not replicate circadian rhythms and has unpleasant side effects especially due to the failure to restore normal function of the hypothalamic-pituitary-adrenal (HPA) axis. Adrenal cell transplantation and the restoration of HPA axis function would be a feasible and useful therapeutic strategy for patients with adrenal insufficiency. We created a bioartificial adrenal with 3D cell culture conditions by encapsulation of bovine adrenocortical cells (BACs) in alginate (enBACs). We found that, compared with BACs in monolayer culture, encapsulation in alginate significantly increased the life span of BACs. Encapsulation also improved significantly both the capacity of adrenal cells for stable, long-term basal hormone release as well as the response to pituitary adrenocorticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6]LHRH. The enBACs were transplanted into adrenalectomized, immunodeficient, and immunocompetent rats. Animals received enBACs intraperitoneally, under the kidney capsule (free cells or cells encapsulated in alginate slabs) or s.c. enclosed in oxygenating and immunoisolating βAir devices. Graft function was confirmed by the presence of cortisol in the plasma of rats. Both types of grafted encapsulated cells, explanted after 21-25 d, preserved their morphology and functional response to ACTH stimulation. In conclusion, transplantation of a bioartificial adrenal with xenogeneic cells may be a treatment option for patients with adrenocortical insufficiency and other stress-related disorders. Furthermore, this model provides a microenvironment that ensures 3D cell-cell interactions as a unique tool to investigate new insights into cell biology, differentiation, tissue organization, and homeostasis.",
keywords = "Adrenal, Alginate encapsulation, Cell transplantation, LHRH",
author = "Mariya Balyura and Evgeny Gelfgat and Monika Ehrhart-Bornstein and Barbara Ludwig and Zohar Gendlerc and Uriel Barkai and Baruch Zimerman and Avi Rotem and Block, {Norman L} and Schally, {Andrew V} and Bornstein, {Stefan R.}",
year = "2015",
month = "2",
day = "24",
doi = "10.1073/pnas.1500242112",
language = "English",
volume = "112",
pages = "2527--2532",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - Transplantation of bovine adrenocortical cells encapsulated in alginate

AU - Balyura, Mariya

AU - Gelfgat, Evgeny

AU - Ehrhart-Bornstein, Monika

AU - Ludwig, Barbara

AU - Gendlerc, Zohar

AU - Barkai, Uriel

AU - Zimerman, Baruch

AU - Rotem, Avi

AU - Block, Norman L

AU - Schally, Andrew V

AU - Bornstein, Stefan R.

PY - 2015/2/24

Y1 - 2015/2/24

N2 - Current treatment options for adrenal insufficiency are limited to corticosteroid replacement therapies. However, hormone therapy does not replicate circadian rhythms and has unpleasant side effects especially due to the failure to restore normal function of the hypothalamic-pituitary-adrenal (HPA) axis. Adrenal cell transplantation and the restoration of HPA axis function would be a feasible and useful therapeutic strategy for patients with adrenal insufficiency. We created a bioartificial adrenal with 3D cell culture conditions by encapsulation of bovine adrenocortical cells (BACs) in alginate (enBACs). We found that, compared with BACs in monolayer culture, encapsulation in alginate significantly increased the life span of BACs. Encapsulation also improved significantly both the capacity of adrenal cells for stable, long-term basal hormone release as well as the response to pituitary adrenocorticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6]LHRH. The enBACs were transplanted into adrenalectomized, immunodeficient, and immunocompetent rats. Animals received enBACs intraperitoneally, under the kidney capsule (free cells or cells encapsulated in alginate slabs) or s.c. enclosed in oxygenating and immunoisolating βAir devices. Graft function was confirmed by the presence of cortisol in the plasma of rats. Both types of grafted encapsulated cells, explanted after 21-25 d, preserved their morphology and functional response to ACTH stimulation. In conclusion, transplantation of a bioartificial adrenal with xenogeneic cells may be a treatment option for patients with adrenocortical insufficiency and other stress-related disorders. Furthermore, this model provides a microenvironment that ensures 3D cell-cell interactions as a unique tool to investigate new insights into cell biology, differentiation, tissue organization, and homeostasis.

AB - Current treatment options for adrenal insufficiency are limited to corticosteroid replacement therapies. However, hormone therapy does not replicate circadian rhythms and has unpleasant side effects especially due to the failure to restore normal function of the hypothalamic-pituitary-adrenal (HPA) axis. Adrenal cell transplantation and the restoration of HPA axis function would be a feasible and useful therapeutic strategy for patients with adrenal insufficiency. We created a bioartificial adrenal with 3D cell culture conditions by encapsulation of bovine adrenocortical cells (BACs) in alginate (enBACs). We found that, compared with BACs in monolayer culture, encapsulation in alginate significantly increased the life span of BACs. Encapsulation also improved significantly both the capacity of adrenal cells for stable, long-term basal hormone release as well as the response to pituitary adrenocorticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D-Trp6]LHRH. The enBACs were transplanted into adrenalectomized, immunodeficient, and immunocompetent rats. Animals received enBACs intraperitoneally, under the kidney capsule (free cells or cells encapsulated in alginate slabs) or s.c. enclosed in oxygenating and immunoisolating βAir devices. Graft function was confirmed by the presence of cortisol in the plasma of rats. Both types of grafted encapsulated cells, explanted after 21-25 d, preserved their morphology and functional response to ACTH stimulation. In conclusion, transplantation of a bioartificial adrenal with xenogeneic cells may be a treatment option for patients with adrenocortical insufficiency and other stress-related disorders. Furthermore, this model provides a microenvironment that ensures 3D cell-cell interactions as a unique tool to investigate new insights into cell biology, differentiation, tissue organization, and homeostasis.

KW - Adrenal

KW - Alginate encapsulation

KW - Cell transplantation

KW - LHRH

UR - http://www.scopus.com/inward/record.url?scp=84923683258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923683258&partnerID=8YFLogxK

U2 - 10.1073/pnas.1500242112

DO - 10.1073/pnas.1500242112

M3 - Article

C2 - 25675525

AN - SCOPUS:84923683258

VL - 112

SP - 2527

EP - 2532

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -